Definitive Contract 75D30123C17500
Award Date 8/24/23
Potential Completion Date 8/7/24
Potential Value $92K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,205,550.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York to provide support for translational and operational science and technology to improve the CDC. The contract has an ultimate completion date of September 12, 2024 and was awarded on September 13, 2022. This contract is not set aside. Columbia University, a leading academic research institution, will leverage...
- This is a firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York (Columbia University) for an NHSN Adoption Study. The contract has a ceiling value of $371,995.00 and a completion date of September 19, 2018. The contract was not set aside for any specific designation. Columbia University is a renowned private research institution that frequently collaborates with federal agencies through both...
- The Centers for Disease Control and Prevention (CDC) awarded a $246,462 firm-fixed-price purchase order to The Trustees of Columbia University in the City of New York, Health Sciences Division, to conduct a MPOX self-collection study. The contract has a period of performance through September 14, 2024 and does not have a set-aside designation. Columbia University is a private university and non-profit organization with extensive experience conducting biomedical research and providing services to...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $481,380.00 firm fixed-price definitive contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, to perform a "Prospective Assessment of Neurologic Manifestations of SARS-CoV-2 Infection in Hospitalized Patients." The contract does not have a set-aside designation and is scheduled for completion by August 31, 2023. As a...
- The Centers for Disease Control and Prevention awarded a $154,876 delivery order contract to The Trustees of Columbia University in New York, New York. The contract supports research entitled "TB in the U.S.: Epidemiology and Prevention Opportunities" through September 14, 2010. As a private, non-profit educational institution, Columbia University will provide subject matter expertise and analysis to the CDC regarding tuberculosis trends, transmission dynamics, and strategies for...
- This is a delivery order contract awarded to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, by the Centers for Disease Control and Prevention (CDC). The $774,425 contract is for the CISA RSV INFANTS STUDY (CONTRIBUTING SITE) and does not have a set-aside designation. The contract is a cost-no-fee type with a period of performance through September 26, 2027. As a leading research institution, Columbia University has extensive...
- This federal contract award to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, is for a Pediatric COVID-19 Vaccination Randomized Controlled Trial (RCT). The award, valued at $730,877, was made by the Centers for Disease Control and Prevention (CDC) under the Clinical Immunization Safety Assessment (CISA) contract vehicle. The contract has a period of performance ending on December 28, 2025. There is no set-aside designation for this...
- The Centers for Disease Control and Prevention (CDC) awarded a $249,572 firm fixed price purchase order to The Trustees of Columbia University in the City of New York, operating as the Health Sciences Division, to conduct a MPOX viral persistency study. As the prime contractor, Columbia University will perform the study under the contract's one-year period of performance in New York, New York. The CDC aims to enhance understanding of MPOX through research administered under its broader health...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a private university and non-profit organization. The $499,857 Delivery Order is part of the CDC's Clinical Immunization Safety Assessment (CISA) indefinite delivery contract, which supports ongoing monitoring and evaluation of vaccine safety as part of the agency's disease prevention...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $206,875 delivery order to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to provide clinical immunization safety assessment services. This delivery order is part of a larger $86 million indefinite delivery contract awarded by the CDC to Columbia University in September 2023 to provide these services from 2023 to 2028. The contract...